Published in Hepatol Res on August 29, 2020
Indocyanine Green Fluorescent Imaging for Hepatic Resection of the Right Hepatic Vein Drainage Area. J Am Coll Surg (2015) 2.05
Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide survey. Transpl Int (2014) 1.49
Selection of a right posterior sector graft for living donor liver transplantation. Liver Transpl (2014) 1.38
Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study. J Hepatobiliary Pancreat Sci (2015) 1.22
CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property. Int J Cancer (2015) 1.00
Amphipathic α-helices in apolipoproteins are crucial to the formation of infectious hepatitis C virus particles. PLoS Pathog (2014) 0.93
Skeletal muscle area correlates with body surface area in healthy adults. Hepatol Res (2013) 0.90
Optimizing risk stratification in portal vein thrombosis after splenectomy and its primary prophylaxis with antithrombin III concentrates and danaparoid sodium in liver cirrhosis with portal hypertension. J Am Coll Surg (2014) 0.89
Impact of tumor size, number of tumors and neutrophil-to-lymphocyte ratio in liver transplantation for recurrent hepatocellular carcinoma. Hepatol Res (2012) 0.88
Pathological analysis of opened round ligaments as venous patch grafts in living donor liver transplantation. Liver Transpl (2013) 0.87
Living donor liver transplantation for acute liver failure: a 10-year experience in a single center. J Am Coll Surg (2007) 0.85
Prediction of lymph node metastasis in patients with submucosa-invading early gastric cancer. Anticancer Res (2014) 0.84
Curative Resection After Gemcitabine, Cisplatin and S-1 Chemotherapy for Initially Unresectable Biliary Duct Cancer: A Case Report. Anticancer Res (2015) 0.84
A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation. Hepatology (2016) 0.84
Roles of Lipoproteins and Apolipoproteins in Particle Formation of Hepatitis C Virus. Trends Microbiol (2015) 0.84
Postoperative complications are predictive of poor prognosis in hepatocellular carcinoma. J Surg Res (2015) 0.83
Impact of donor age and recipient status on left-lobe graft for living donor adult liver transplantation. Transpl Int (2007) 0.83
A Phased Desensitization Protocol With Rituximab and Bortezomib for Highly Sensitized Kidney Transplant Candidates. Transplant Direct (2015) 0.82
Predictors of intrahepatic multiple recurrences after curative hepatectomy for hepatocellular carcinoma. Anticancer Res (2015) 0.82
Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma. J Am Coll Surg (2014) 0.81
Unique clinical courses of transfusion-transmitted hepatitis E in patients with immunosuppression. Transfusion (2017) 0.81
Telaprevir versus simeprevir for the treatment of recurrent hepatitis C after living donor liver transplantation. Hepatol Res (2015) 0.80
Long-term outcome of living-donor liver transplantation for combined hepatocellular-cholangiocarcinoma. Anticancer Res (2015) 0.80
Hepatic Sclerosed Hemangioma: a case report and review of the literature. BMC Surg (2015) 0.80
A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2. Cancer Res (2016) 0.80
The apelin-APJ system induces tumor arteriogenesis in hepatocellular carcinoma. Anticancer Res (2014) 0.79
Successful pylorus-preserving pancreaticoduodenectomy for a patient with carcinoma of the papilla Vater two years after living donor liver transplantation. Hepatogastroenterology (2007) 0.79
Does reduced-port laparoscopic surgery for medically uncontrolled ulcerative colitis do more harm than good? Asian J Endosc Surg (2015) 0.79
Lipoprotein Receptors Redundantly Participate in Entry of Hepatitis C Virus. PLoS Pathog (2016) 0.79
Living Donor Liver Transplantation for Hepatocellular Carcinoma within Milan Criteria in the Present Era. Anticancer Res (2016) 0.79
Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas. Histopathology (2016) 0.79
Successful adult-to-adult living donor liver transplantation using liver allograft after the resection of hemangioma: A suggestive case for a further expansion of living donor pool. Int J Surg Case Rep (2015) 0.79
Surgical results for recurrent hepatocellular carcinoma after curative hepatectomy: Repeat hepatectomy versus salvage living donor liver transplantation. Liver Transpl (2015) 0.78
Simultaneous pancreas and kidney composite graft transplantation with retroperitoneal systemic-enteric drainage. Ann Transplant (2014) 0.78
Cytomegalovirus (CMV) Monitoring After Liver Transplantation: Comparison of CMV Pp65 Antigenemia Assay with Real-Time PCR Calibrated to WHO International Standard. Ann Transplant (2016) 0.78
Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma. World J Surg (2017) 0.78
Outcomes of adult-to-adult living donor liver transplantation in 321 recipients. Liver Transpl (2016) 0.78
Significance of stroke volume variation during hepatic resection under infrahepatic inferior vena cava and portal triad clamping. Fukuoka Igaku Zasshi (2013) 0.78
Postoperative assessment of hepatic asialoglycoprotein receptor function with Tc-99m GSA: the safety margin of resection size in living donor liver transplantation. Ann Transplant (2015) 0.78
Changes in expression levels of ERCC1, DPYD, and VEGFA mRNA after first-line chemotherapy of metastatic colorectal cancer: results of a multicenter study. Oncotarget (2015) 0.78
Laparoscopy-Specific Surgical Concepts for Hepatectomy Based on the Laparoscopic Caudal View: A Key to Reboot Surgeons' Minds. Ann Surg Oncol (2015) 0.77
Human Cathelicidin Compensates for the Role of Apolipoproteins in Hepatitis C Virus Infectious Particle Formation. J Virol (2016) 0.77
Case of early adenosquamous carcinoma of the stomach. Fukuoka Igaku Zasshi (2013) 0.77
Prognostic significance of ZNF217 expression in gastric carcinoma. Anticancer Res (2014) 0.77
Prediction of long-term survival by using the Glasgow Prognostic Score in patients with hepatocellular carcinoma after liver transplantation. Hepatol Res (2015) 0.77
Bloodless splenectomy during liver transplantation for terminal liver diseases with portal hypertension. J Am Coll Surg (2008) 0.77
Recurrence 11 years after complete response to gemcitabine, 5-Fluorouracil, and Cisplatin chemotherapy followed by radiotherapy in a patient with advanced pancreatic cancer: a case report. Anticancer Res (2015) 0.77
Changes in Surgical Site Infections after Living Donor Liver Transplantation. PLoS One (2015) 0.77
Profile of plasma amino acids values as a predictor of sepsis in patients following living donor liver transplantation: Special reference to sarcopenia and postoperative early nutrition. Hepatol Res (2015) 0.77
Diverse Basis of β-Catenin Activation in Human Hepatocellular Carcinoma: Implications in Biology and Prognosis. PLoS One (2016) 0.76
Hepatocyte Factor JMJD5 Regulates Hepatitis B Virus Replication through Interaction with HBx. J Virol (2016) 0.76
Uracil-Tegafur and Oral Leucovorin Combined With Bevacizumab in Elderly Patients (Aged ≥ 75 Years) With Metastatic Colorectal Cancer: A Multicenter, Phase II Trial (Joint Study of Bevacizumab, Oral Leucovorin, and Uracil-Tegafur in Elderly Patients [J-BLUE] Study). Clin Colorectal Cancer (2015) 0.76
Laparoscopic Splenectomy with Technical Standardization and Selection Criteria for Standard or Hand-Assisted Approach in 390 Patients with Liver Cirrhosis and Portal Hypertension. J Am Coll Surg (2015) 0.76
Sarcopenia is a poor prognostic factor following hepatic resection in patients aged 70 years and older with hepatocellular carcinoma. Hepatol Res (2016) 0.76
Impact of human T-cell leukemia virus type 1 on living donor liver transplantation: a multi-center study in Japan. J Hepatobiliary Pancreat Sci (2016) 0.76
Auxiliary partial orthotopic liver transplantation from living donors. Surgery (2002) 0.75
Treatment of hepatic amyloid light-chain amyloidosis with bortezomib and dexamethasone in a liver transplant patient. Hepatol Res (2015) 0.75
Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice. PLoS One (2017) 0.75
Living Donor Liver Transplantation Using a Liver Graft With Congenital Intrahepatic Portosystemic Shunt. Transplant Direct (2015) 0.75
Quasispecies of Hepatitis C Virus Participate in Cell-Specific Infectivity. Sci Rep (2017) 0.75
A multi-institutional feasibility study of S-1/oxaliplatin plus bevacizumab in patients with advanced/metastatic colorectal cancer: the HiSCO-02 prospective phase II study. Springerplus (2016) 0.75
Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition. Cancer Med (2017) 0.75
Obstructive Jaundice Due to Hilar Bile Duct Compression with Encasement of the Right Hepatic Artery. Gastroenterology Res (2009) 0.75
Multicentre, randomised, placebo-controlled trial of extract of Japanese herbal medicine Daikenchuto to prevent bowel dysfunction after adult liver transplantation (DKB 14 Study). BMJ Open (2015) 0.75
Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma. Mol Cancer (2016) 0.75
Outcomes of Living Donor Liver Transplantation Alone for Patients on Maintenance Renal Replacement Therapy in Japan: Results of a Nationwide Survey. Transplant Direct (2016) 0.75
Fasting enhances TRAIL-mediated liver natural killer cell activity via HSP70 upregulation. PLoS One (2014) 0.75
Suppression of silent information regulator 1 activity in noncancerous tissues of hepatocellular carcinoma: Possible association with non-B non-C hepatitis pathogenesis. Cancer Sci (2015) 0.75
Impact of umbilical polyp resection: A report and literature review. Afr J Paediatr Surg (2017) 0.75
Jejunal intussusception caused by metastasis of a giant cell carcinoma of the lung. BMJ Case Rep (2016) 0.75
A case of cholangiolocellular carcinoma featuring intratumoral hepatic artery penetration: A case report. Int J Surg Case Rep (2017) 0.75
Clinical prognostic value of DNA methylation in hepatoblastoma: Four novel tumor suppressor candidates. Cancer Sci (2016) 0.75
Cystic liver infection after living donor liver transplantation: a case report. Case Rep Gastroenterol (2014) 0.75
Effect of Sarcopenic Obesity on Outcomes of Living-Donor Liver Transplantation for Hepatocellular Carcinoma. Anticancer Res (2016) 0.75
Skeletal muscle mass assessed by computed tomography correlates to muscle strength and physical performance at a liver-related hospital experience. Hepatol Res (2015) 0.75
Liver transplantation followed by pulmonary resection complicated with end-stage liver cirrhosis: a case report. Anticancer Res (2015) 0.75
Re-evaluation of the predictive score for 6-month graft survival in living donor liver transplantation in the modern era. Liver Transpl (2014) 0.75
Surgical Indications for Hepatocellular Carcinoma with Non-hypervascular Hypointense Nodules Detected by Gd-EOB-DTPA-Enhanced MRI. Ann Surg Oncol (2020) 0.75
Impact of Recombinant Human Soluble Thrombomodulin for Disseminated Intravascular Coagulation. Anticancer Res (2016) 0.75
Thoracoscopic pericardial drainage for gastric tube ulcer penetrated into the pericardium. Fukuoka Igaku Zasshi (2013) 0.75